谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Clinical Management of Second-Generation Tyrosine Kinase Inhibitor Therapy in Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Chronic Phase, Focusing on Age and Dose Effects.

Michihide Tokuhira,Yuta Kimura,Takayuki Tabayashi,Naoki Watanabe,Shun Tsuchiya,Tomoiku Takaku,Noriyoshi Iriyama,Eriko Sato,Tomonori Nakazato,Toru Mitsumori,Maho Ishikawa,Hiroyuki Fujita,Masahiro Kizaki,Miki Ando,Yoshihiro Hatta,Eisaku Iwanaga,Tatsuya Kawaguchi

INTERNATIONAL JOURNAL OF HEMATOLOGY（2023）

引用 0|浏览5
暂无评分
关键词
Chronic myeloid leukemia,Dasatinib,Nilotinib,Younger,Elderly,Dose
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要